News Releases | Lexicon Pharmaceuticals, Inc.

Press Releases

Title	Published Date
Lexicon Pharmaceuticals to Participate in the Jefferies 2022 Healthcare Conference	Jun 01, 2022
Lexicon Resubmits New Drug Application for Sotagliflozin for the Treatment of Heart Failure	May 31, 2022
Lexicon Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Clinical Update	May 05, 2022
Lexicon Pharmaceuticals to Host First Quarter 2022 Financial Results Conference Call and Webcast on May 5, 2022	Apr 29, 2022
Lexicon Pharmaceuticals to Participate in the 21st Annual Needham Virtual Healthcare Conference	Apr 07, 2022
Lexicon Welcomes New Guidelines for the Management of Heart Failure	Apr 04, 2022
Sotagliflozin Improved Outcomes in Patients with and without Prior Cardiovascular Disease in New Analysis Presented at the American College of Cardiology’s 71st Annual Scientific Session (ACC.22)	Apr 02, 2022
New Analysis of Cardiovascular Endpoints in the SCORED Trial to be Presented at the American College of Cardiology’s 71st Annual Scientific Session (ACC.22)	Mar 21, 2022
Lexicon Enters Into Loan Facility with Oxford Finance for up to $150 Million to Support Planned Commercialization of Sotagliflozin	Mar 17, 2022
Lexicon Pharmaceuticals Reports Fourth Quarter and Full-Year 2021 Financial Results and Provides Clinical Update	Feb 28, 2022